CN110314134B - 一种胃肠镜检查辅助用水及其制备方法 - Google Patents
一种胃肠镜检查辅助用水及其制备方法 Download PDFInfo
- Publication number
- CN110314134B CN110314134B CN201910677618.4A CN201910677618A CN110314134B CN 110314134 B CN110314134 B CN 110314134B CN 201910677618 A CN201910677618 A CN 201910677618A CN 110314134 B CN110314134 B CN 110314134B
- Authority
- CN
- China
- Prior art keywords
- water
- parts
- weight
- gastrointestinal
- ultrasonic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 103
- 230000002496 gastric effect Effects 0.000 title claims abstract description 39
- 238000001839 endoscopy Methods 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 claims abstract description 13
- 239000008213 purified water Substances 0.000 claims abstract description 11
- 239000002518 antifoaming agent Substances 0.000 claims abstract description 7
- 239000004094 surface-active agent Substances 0.000 claims abstract description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 10
- 239000003208 petroleum Substances 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 9
- -1 polyoxypropylene ethylene oxide glycerol Polymers 0.000 claims description 9
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 8
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 claims description 8
- 230000001186 cumulative effect Effects 0.000 claims description 8
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 claims description 8
- 229940043276 diisopropanolamine Drugs 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 7
- RBNPOMFGQQGHHO-UHFFFAOYSA-N glyceric acid Chemical compound OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 229920001661 Chitosan Polymers 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 229920002689 polyvinyl acetate Polymers 0.000 claims description 4
- 239000011118 polyvinyl acetate Substances 0.000 claims description 4
- 239000004378 Glycyrrhizin Substances 0.000 claims description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 3
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 229960000502 poloxamer Drugs 0.000 claims description 2
- 229920001983 poloxamer Polymers 0.000 claims description 2
- 239000012676 herbal extract Substances 0.000 claims 2
- 239000004615 ingredient Substances 0.000 claims 1
- 238000000527 sonication Methods 0.000 claims 1
- 230000000052 comparative effect Effects 0.000 description 26
- 238000009210 therapy by ultrasound Methods 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 238000001179 sorption measurement Methods 0.000 description 9
- 210000001035 gastrointestinal tract Anatomy 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 6
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 238000002834 transmittance Methods 0.000 description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- 239000003610 charcoal Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000004051 gastric juice Anatomy 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000008238 Muscle Spasticity Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000016160 smooth muscle contraction Effects 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 208000018198 spasticity Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/273—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the upper alimentary canal, e.g. oesophagoscopes, gastroscopes
- A61B1/2736—Gastroscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/31—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the rectum, e.g. proctoscopes, sigmoidoscopes, colonoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
样品 | 吸附率(%) |
实施例7 | 37.7 |
对照例9 | 1.3 |
对照例10 | 0.8 |
对照例11 | 7.4 |
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2019100692931 | 2019-01-24 | ||
CN201910069293 | 2019-01-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110314134A CN110314134A (zh) | 2019-10-11 |
CN110314134B true CN110314134B (zh) | 2021-07-23 |
Family
ID=68124651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910677618.4A Active CN110314134B (zh) | 2019-01-24 | 2019-07-25 | 一种胃肠镜检查辅助用水及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110314134B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111297889A (zh) * | 2020-02-28 | 2020-06-19 | 奥纳斯(北京)医药科技有限公司 | 一种对胃肠道痉挛和胆道系统痉挛均具有抑制作用的组合物、其水溶液及其制法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104263536A (zh) * | 2014-10-17 | 2015-01-07 | 景丽 | 一种手机屏幕清洁剂及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1097456C (zh) * | 1997-12-22 | 2003-01-01 | 永信药品工业股份有限公司 | 胃肠消泡锭剂的制造方法及其应用 |
AU2007297697A1 (en) * | 2006-09-20 | 2008-03-27 | Monosol Rx Llc | Edible water-soluble film containing a foam reducing flavoring agent |
CN104436247A (zh) * | 2014-06-03 | 2015-03-25 | 王鹏 | 一种利用超声检测胃肠疾病的造影剂及其制备方法 |
CN104491884B (zh) * | 2014-12-04 | 2017-08-25 | 济南市儿童医院 | 一种含中药成分的胃肠造影剂 |
CN109200278A (zh) * | 2018-10-08 | 2019-01-15 | 毛玉坤 | 腔镜去粘液消泡剂及其制备方法 |
-
2019
- 2019-07-25 CN CN201910677618.4A patent/CN110314134B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104263536A (zh) * | 2014-10-17 | 2015-01-07 | 景丽 | 一种手机屏幕清洁剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110314134A (zh) | 2019-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110314134B (zh) | 一种胃肠镜检查辅助用水及其制备方法 | |
CN104435990A (zh) | 促进腹部术后胃肠功能恢复的中药组合物及其制备方法 | |
CN108403646B (zh) | 阿苯达唑纳米微粉及其制备方法 | |
CN106361993A (zh) | 一种防治胃黏膜损伤的药物组合物及其制备方法 | |
CN103622951A (zh) | 莲必治口服液体制剂其制备方法 | |
CN1686501A (zh) | 一种治疗小儿腹泻的中药复方制剂及其制备方法 | |
CN1686377A (zh) | 一种喘可治粉针剂及其制备方法 | |
CN102178695B (zh) | 猪胆汁结合型总胆酸的制备方法及其应用 | |
CN1287855C (zh) | B型慢性肝炎治疗剂 | |
CN1172433A (zh) | 胃溃宁制剂 | |
CN1141101C (zh) | 治疗乙肝的药物及其制备方法 | |
CN1289505C (zh) | 新化合物藤黄新酸的化学结构及以其为活性成份的药物制剂和用途 | |
CN1292750C (zh) | 植物来源总生物碱组合物及其药物制剂 | |
CN110327471B (zh) | 一种内镜检查解痉消泡剂及其制备方法 | |
CN1468602A (zh) | 柚皮苷在制备支持性治疗非典型性肺炎药物中的应用 | |
CN1164267C (zh) | 绿原酸的医学用途及它的制剂 | |
CN106420922A (zh) | 一种促术后胃肠动力和治疗功能性便秘的中药外用制剂 | |
CN1255146C (zh) | 一种治疗上呼吸道感染的药物组合物及其制备方法 | |
CN1406585A (zh) | 一种治疗病毒性心肌炎的药物组合物 | |
CN1686091A (zh) | 二苯基庚酮类化合物的组合物及它的用途 | |
CN1839867A (zh) | 具有清热、泻火和解毒作用的药物组合物 | |
CN115869357B (zh) | 一种治疗哮喘的药菌组合物及其制备方法与应用 | |
CN1119157C (zh) | 止咳、祛痰、平喘胶囊及其制备方法 | |
CN1634461A (zh) | 一种银黄冻干粉针剂及其制备方法 | |
CN103223058B (zh) | 牡荆子总黄酮提取物及其制备方法和医药用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20210527 Address after: 100094 No. 4009-14, 4th floor, block B, building 1, yard 2, Yongcheng North Road, Haidian District, Beijing Applicant after: Onas (Beijing) Pharmaceutical Technology Co.,Ltd. Address before: 100102 room 310, 3rd floor, building 605, wangjingyuan, Chaoyang District, Beijing Applicant before: BEIJING GEFEI MEDICAL DEVICES Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231101 Address after: Room 6619, 6th Floor, Building 2, No. 9 Xiaotun Road, Fengtai District, Beijing, 100141 Patentee after: Beijing Yiliya Medical Technology Co.,Ltd. Address before: 100094 No. 4009-14, 4th floor, block B, building 1, yard 2, Yongcheng North Road, Haidian District, Beijing Patentee before: Onas (Beijing) Pharmaceutical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right |